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Abstract This paper describes the synthesis of methylcelluloses end-18 
functionalized with peptides and an investigation into their functions. We found 19 
that aqueous solutions of methylcellulose end-functionalized not only with 20 
carbohydrates but also with peptide segments, such as di(arginine) and 21 
di(glutamic acid), behave as thermoresponsive supramolecular hydrogelators at 22 
human-body temperature. The slow drug release from thermoresponsive 23 
hydrogels of methylcelluloses end-functionalized with peptides is attributed to 24 
ionic interactions between model drugs and peptide segments in these hydrogels. 25 
Reactions of methylated cellobiose with di(arginine) and di(glutamic acid) were 26 
used to determine optimum reaction conditions for the synthesis of 27 
methylcelluloses end-functionalized with these peptide residues). The surface 28 
activities, zeta potentials, thermal properties, hydrogelation behavior, and 29 
cytotoxicities of these peptide-functionalized methylcelluloses are also discussed. 30 
  31 
3 
Highlights: 32 
• Methylcelluloses end-functionalized with peptides were synthesized. 33 
• Peptides-end-functionalized methylcelluloses behave as thermoresponsive 34 
supramolecular hydrogelators at human-body temperature. 35 
• The slow drug release from thermoresponsive hydrogels of methylcelluloses 36 
end-functionalized with peptides was achieved. 37 
 38 
Graphical Abstract: 39 
 40 
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Introduction 42 
Thermoresponsive hydrogels have received increased attention in recent years. 43 
In particular, thermoresponsive supramolecular hydrogels (Du et al. 2015) with 44 
lower critical solution temperatures (LCSTs) (Yamagami et al. 2018) enable the 45 
development of biomedical applications such as injectable drug-delivery 46 
technology (Baumann et al. 2009). While poly(N-isopropylacrylamide) 47 
(Fundueanu et al. 2009) is a well known thermoresponsive polymer derived from 48 
fossil resources, methylcellulose (MC) is a thermoresponsive material from 49 
renewable resources. 50 
The degree of substitution (DS) of industrially produced MC is 1.8, and its 51 
aqueous solution exhibits thermoreversible hydrogelation at approximately 60 °C. 52 
The physical properties of aqueous MC solutions have received considerable 53 
academic attention (Desbrieres et al. 1998; Heymann 1935; Rees 1972; Savage 54 
1957). Kato et al. concluded that the network junction points in MC gels are 55 
between 4 and 8 units long (Kato et al. 1978).  56 
Our studies have focused on structure-property-function relationships of 57 
methylcellulose (Kamitakahara et al. 2009a; Kamitakahara et al. 2009b; 58 
Kamitakahara et al. 2008a; Kamitakahara et al. 2012; Kamitakahara and 59 
Nakatsubo 2010; Kamitakahara et al. 2006; Kamitakahara et al. 2007; 60 
Kamitakahara et al. 2009c; Kamitakahara et al. 2008b; Karakawa et al. 2002; 61 
Nakagawa et al. 2011a; Nakagawa et al. 2011b; Nakagawa et al. 2012a; 62 
Nakagawa et al. 2012b; Nakagawa et al. 2012c). Diblock methylcellulose bearing 63 
a sequence of at least ten 2,3,6-tri-O-methylglucosyl units and an unmodified 64 
cellobiosyl unit plays a crucial role in the thermoreversible hydrogelation of an 65 
aqueous MC solution (Nakagawa et al. 2011a).  66 
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Our detailed study on the structure-property relationships of methylcellulose 67 
with a sequence of over twenty 2,3,6-tri-O-methylglucosyl units revealed the 68 
thermoreversible hydrogelation properties of an aqueous diblock methylcellulose 69 
solution at human-body temperature (Nakagawa et al. 2011a). In addition, Bodvik 70 
et al. reported that MC forms fibrillar aggregates that were observed by cryogenic 71 
transmission electron microscopy (Cryo-TEM) (Bodvik et al. 2010); we also 72 
reported the same morphology (Nakagawa et al. 2012c), as did the group of 73 
Lodge (Lott et al. 2013a; Lott et al. 2013b). Moreover, we found that well-defined 74 
diblock methylcellulose self-assembles thermoresponsively into ribbon-like 75 
nanostructures in water to form a thermoreversible hydrogel at human-body 76 
temperature (Nakagawa et al. 2012c). The intermolecular interactions in the 77 
fibrillar nanostructure of commercial MC in aqueous solution at LCST and in the 78 
ribbon-like nanostructure of well-defined diblock methylcellulose are essentially 79 
the same; hydrophobic interactions between a sequence of 2,3,6-tri-O-80 
methylglucosyl units, and hydrogen bonding between less-methylated glucosyl 81 
units both play crucial roles during the aggregation of methylcellulose molecules 82 
at LCST. 83 
This finding prompted us to explore methylcellulose analogues that can be 84 
synthesized by more simple and straightforward methods than glycosylation 85 
(Nakagawa et al. 2011b). We selected the Huisgen 1,3-dipolar cycloaddition 86 
reaction for the development of methylcellulose analogues (Nakagawa et al. 87 
2012b). An aqueous solution of the newly synthesized methylcellulose analogue, 88 
which included hydrophobic and hydrophilic segments connected by 1,2,3-89 
triazoles, exhibited thermoreversible hydrogelation properties (Nakagawa et al. 90 
2012b) equivalent to that of a well-defined diblock methylcellulose (Nakagawa et 91 
al. 2011b). Consequently, we developed a synthetic method for the end-92 
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functionalization of methylcellulose to produce methylcellulosyl azide and 93 
propargyl methylcelluloside (Kamitakahara et al. 2016). Moreover, not only did 94 
nonionic segments, such as cellobiosyl units (as hydrophilic blocks) induce 95 
thermoreversible hydrogelation, but ionic segments did as well (Yamagami et al. 96 
2018), although it was crucial that the concentrations of the diblock 97 
methylcellulose analogues in aqueous media remain at 4 wt%. 98 
Our recent results suggested that it might be possible to install any functional 99 
group at the methylcellulose end and retain thermoreversible hydrogelation 100 
behavior at human-body temperature. Hence, we explored the end-101 
functionalization of methylcellulose with peptides. Peptides exhibit potent 102 
biological activities due to the functional diversity of their amino-acid chains, and 103 
play crucial roles in organisms that differ from those of oligo- and 104 
polysaccharides. Therefore, the end-functionalizations of polysaccharide 105 
derivatives with peptides are expected to yield a variety of functional materials 106 
that exhibit thermoresponsive properties. An oligosaccharide-based synthetic 107 
glycoprotein (Bonduelle and Lecommandoux 2013) has been reported by the 108 
group of Lecommandoux. However, polysaccharide-derivative-block-109 
oligosaccharides (Breitenbach et al. 2017; de Medeiros Modolon et al. 2012) or 110 
polysaccharide-derivative-block-oligopeptides have not received much attention 111 
from researchers. Carbohydrate-based block copolymers with polyester (Fajardo 112 
et al. 2014; Liu and Zhang 2007), poly(methyl methacrylate) (Dax et al. 2013; 113 
Togashi et al. 2014), poly(styrene) (Loos and Müller 2002; Otsuka et al. 2013; 114 
Yagi et al. 2010), poly(N-isopropylacrylamide) (Dax et al. 2013; Otsuka et al. 115 
2012), poly(γ-benzyl-L-glutamate) (Kamitakahara et al. 2014), and poly(3-116 
hexylthiophene) (Sakai-Otsuka et al. 2017) polyisoprene (Hung et al. 2017), and 117 
poly(ethyleneoxide) (Akiyoshi et al. 1999) have been reported. Shoichet and her 118 
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colleagues focused on a physical blend of hyaluronan and methylcellulose 119 
covalently linked to peptides for tissue-engineering purposes (Parker et al. 2016). 120 
They modified methylcellulose with peptides by the "grafting to" method, in 121 
which peptide moieties were randomly introduced onto the methylcellulose 122 
backbone. In contrast, our method gives thermoresponsive hydrogels composed of 123 
only methylcellulose and peptides, and are devoid of other polysaccharides. Our 124 
new peptide-end-functionalized methylcelluloses are linear polysaccharide 125 
derivatives with blocky structures that exhibit a broad range of new properties, 126 
including thermoreversible hydrogelation at temperatures close to that of the 127 
human body, formation of ribbonlike supramolecular nanostructures by self-128 
assembly, surface activities, and slow drug release from thermoresponsive 129 
supramolecular hydrogel.  130 
Herein, we describe the end-functionalization of tri-O-methylcellulose with 131 
cationic di(arginine) and anionic di(glutamic acid) units as peptide segments in 132 
order to develop new functionality (Chart 1). The synthesis, characterization, and 133 
thermal properties of aqueous solutions of these materials, as well as their zeta 134 
potentials, surface activities, in vitro cytotoxicities, and drug-release behavior 135 
from their supramolecular hydrogel matrices, are discussed. 136 
 137 
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Chart 1. Compounds 1–3. 139 
 140 
 141 
Results and discussion 142 
Synthesis of Peptide Segments 143 
Peptide segments were synthesized following standard Fmoc methodology, as 144 
shown in Scheme 1. For side-chain protection, we used the 2,2,4,6,7-145 
pentamethyldihydrobenzofuran-5-sulfonyl (pbf) group for the guanidine group, 146 
while the γ carboxylic acid group of glutamic acid was protected as a tert-butyl 147 
(tBu) ester.  148 
Propargylamine was reacted with Nα-Fmoc-Nω-Pbf-L-arginine (11) to give the 149 
alkyne-functionalized Nα-Fmoc-Nω-Pbf-L-arginine-N-propargylamide (12) in 150 
89% yield. The amide bond was successfully formed with DMT-MM (Kunishima 151 
et al. 1999a; Kunishima et al. 1999b) as the condensation reagent. The Fmoc 152 
group of compound 12 was removed to afford Nω-Pbf-L-arginine-N-153 
9 
propargylamide (13) in 82% yield. Nα-Fmoc-Nω-Pbf-L-arginine (11) was 154 
coupled with Nω-Pbf-L-arginine-N-propargylamide (13) to produce Nα-Fmoc-155 
Nω-Pbf-L-arginine-Nω-Pbf-L-arginine-N-propargylamide (9) in 89% yield.  156 
Fmoc-Glu(Ot-Bu)-OH (14) was also reacted with propargylamine to produce 157 
the alkyne-functionalized Fmoc-Glu(Ot-Bu)-N-propargylamide (15) in 158 
quantitative yield. Removal of the Fmoc group from compound 15 afforded 159 
Glu(Ot-Bu)-N-propargylamide (16) in quantitative yield. Compounds 14 and 16 160 
were coupled with DMT-MM to produce Nα-Fmoc-Glu(Ot-Bu)-Glu(Ot-Bu)-N-161 
propargylamide (10) in 95% yield. 162 
Compounds 9 and 10, bearing alkyne groups, are peptide-containing segments 163 
for the end-functionalization of methylcellulose. 164 
 165 
Scheme 1. Synthesis of peptide segments 9 and 10. (a) propargylamine / DMT-MM / MeOH /r.t. / 166 
3 h / 89%; (b) piperidine/CH2Cl2 / r.t. / 1 / 82%; (c) DMT-MM / MeOH / r.t. / 4 h / 89%; (d) 167 
propargylamine / DMT-MM / MeOH / r.t. 3 h / quantitative yield; (e) piperidine/CH2Cl2 / r.t. / 1 h 168 
/ quantitative yield; (f) DMT-MM / MeOH / r.t. / 1 h / 95%. 169 
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 170 
Peptide-End-Functionalized Methylcelluloses by Huisgen 1,3-Dipolar 171 
Cycloadditions 172 
Scheme 2 displays the synthetic routes to methylcelluloses end-functionalized 173 
with peptides, as well as the control compounds. Trehalose-type methylated 174 
cellobiose derivative 1a and diblock methylcellulose analogues 1b (Yamagami et 175 
al. 2018) are control compounds for peptide-functionalized methylated cellobiose 176 
derivatives 2a and 3a, and peptide-end-functionalized methylcelluloses 2b and 3b, 177 
respectively.  178 
179 
Scheme 2. Synthesis of methylcelluloses end-functionalized with peptides  180 
a) Cu(I)Br / sodium ascorbate / PMDETA / DMF / r.t. / 21 h / 56%; b) 28% NaOCH3 in MeOH / 181 
MeOH/THF / r.t. / 3 h / quantitative yield; c) CuBr / sodium ascorbate / PMDETA / 182 
MeOH/CH2Cl2/ r.t. / 4 d / 78.5%; d) 28% NaOCH3 in MeOH / MeOH/THF / r.t. / overnight / 183 
quantitative yield; e) Cu(I)Br / sodium ascorbate / MeOH/CH2Cl2/ r.t. / 2 h/ 85%; f) piperidine / 184 
11 
CH2Cl2 / r.t. / 1 h / 65%; TFA/H2O /37 °C / 4 h / 52%; g) CuBr / sodium ascorbate / MeOH / 185 
CH2Cl2 / r.t. / 2 h / 87%; h) piperidine / CH2Cl2 / r.t. / 1 h / 47%; TFA/H2O/ r.t. / 4 h / 58%; i) 186 
CuSO4⋅H2O / sodium ascorbate / MeOH/CH2Cl2 / r.t. / 14 h/ quantitative yield; j) 187 
piperidine/CH2Cl2 / r.t. / 4 h / 89%; TFA/H2O /37 °C / 4 h/ 76%; k) CuSO4⋅H2O / sodium ascorbate 188 
/ MeOH/CH2Cl2 / r.t. / 14 h / 93%; l) piperidine/CH2Cl2 / r.t. / 4 h / 84%; TFA/H2O /r.t. / 4 h / 52%. 189 
 190 
Methylated cellobiose derivatives 2a and 3a were prepared in order to optimize 191 
reaction conditions for the methylcellulose derivatives. Copper-assisted azide-192 
alkyne cycloaddition (CuAAC, the “click reaction”) of 2,3,4,6-tetra-O-methyl-β-193 
D-glucopyranosyl-(1→4)-2,3,6-tri-O-methyl-β-D-glucopyranosyl azide (7a) and 194 
propargylated peptide segments 9 and 10 afforded methylated cellobiose 195 
derivatives 5a (85% yield) and 6a (87% yield) bearing peptide residues, 196 
respectively. Subsequent deprotections of the peptide segments gave methylated 197 
cellobioses 2a and 3a end-functionalized with peptides. 198 
The optimized reaction conditions for the cellobiose derivatives allowed us to 199 
synthesize the peptide-functionalized methylcelluloses 2b and 3b. The CuAAC 200 
reactions of tri-O-methylcellulosyl azide (7b) and propargylated peptide segments 201 
9 and 10 afforded methylcelluloses 5b and 6b end-functionalized with protected 202 
peptides, respectively; deprotection of the peptide segments of these compounds 203 
afforded peptide-functionalized methylcelluloses 2b and 3b.  204 
While tri-O-methylcellulosyl azide (7b) is a mixture of both α- and β-anomers, 205 
the cellobiosyl azide 7a is only the β-anomer. Moreover, each methylcellulose 206 
derivative 7b, 4b, 5b, 6b, 1b, 2b, and 3b bears a single hydroxyl group at the C-4 207 
position of its methylated glucosyl residue furthest from the azide. In contrast, 208 
cellobiosyl azide derivative 7a has no such hydroxyl group. We have reported the 209 
synthesis of blockwise alkylated (1→4) linked trisaccharides, and found that the 210 
anomeric configuration between the hydrophobic and hydrophilic segments 211 




Figure 1 displays the 1H-NMR spectra of cellobiose derivatives 1a, 2a, and 3a 215 
acquired in deuterium oxide. Proton resonances are assigned on the basis of two-216 
dimensional NMR experiments (see experimental section). The triazole protons of 217 
compounds 1a, 2a, and 3a appear at 8.24, 8.19, and 8.24 ppm, respectively. 218 
Carbon resonances of compounds 1a, 2a, and 3a have also been assigned (see 219 
experimental section). Interestingly, the triazole proton of compound 3a appears 220 
as a broad singlet. The methylene protons of compound 3a adjacent to the triazole 221 
ring also appear as a broad peak at about 4.40–4.61 ppm. In addition, the C-1 222 
proton of the cellobiosyl residue appears as a broad doublet at 5.75 ppm.  223 
  The transverse relaxation times T2s of triazole proton and C1 proton adjacent to 224 
the triazole of anionic compound 3a would be shorter than that of compounds 1a 225 
and 2a, although molecular weights of compounds 1a, 2a, and 3a are similar. The 226 
transverse relaxation times T2s of protons of an anionic surfactant, sodium 227 
dodecyl sulfate (SDS), depend on their positions; T2s of the internal protons are 228 
shorter than that of methyl protons and methylene protons adjacent to the sulfate 229 
group (Yu et al. 2017). The transverse relaxation time T2s of the protons of 230 
anionic compound 3a showed the same tendency as the anionic surfactant, SDS. 231 
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 232 
Figure 1. 500-MHz 1H-NMR spectra of compounds 1a, 2a, and 3a in D2O. 233 
 234 
Figure 2 displays the MALDI-TOF MS spectra of compounds 1a, 2a, and 3a. 235 
Pseudomolecular sodium [M+Na]+ and potassium [M+K]+ adduct-ion peaks 236 
corresponding to compound 1a appear at m/z 868.6 and 884.6, respectively. The 237 
pseudomolecular proton adduct-ion peak [M+H]+ of compound 2a appears at m/z 238 
833.6, while pseudomolecular proton [M+H]+, sodium [M+Na]+, and potassium 239 
[M+K]+ adduct-ion peaks of compound 3a appear at m/z 779.5, 801.5, and 817.5, 240 




Figure 2. MALDI-TOF MS spectra of compounds 1a, 2a, and 3a. 244 
 245 
In summary, the NMR and MALDI-TOF MS data for cellobiose derivatives 1a, 246 
2a, and 3a reveal that the conditions for the CuAAC reactions and the 247 
deprotections of the peptide residues are appropriate. Hence, the reaction 248 
conditions developed for these cellobiose derivatives were used to synthesize the 249 
peptide-functionalized methylcelluloses 1b, 2b, and 3b. 250 
15 
 251 
Figure 3. 1H-NMR spectra of compounds 4b, 5b, and 6b in CDCl3. 252 
 253 
Compounds 5b and 6b as well as the trehalose-type diblock methylcellulose 254 
analogue 4b (Yamagami et al. 2018), as an authentic sample of a methylcellulose 255 
end-functionalized with a peptide, were synthesized according to the optimized 256 
reaction conditions for cellobiose derivatives 5a and 6a, as well as 4a. Figure 3 257 
displays the 1H-NMR spectra of compounds 4b, 5b, and 6b acquired in CDCl3. 258 
The triazole proton of compound 4b appears at 7.69 (β-anomer) and 7.70 (α-259 
anomer) ppm (α/β ratio = 2/1) (Yamagami et al. 2018), while the triazole protons 260 
of compounds 5b and 6b were unable to be identified due to overlapping 261 
resonances associated with the aromatic protons of their Fmoc groups, although 262 
proton resonances of the peptide side-chains were observed. 263 
The same deprotection procedures used for the cellobiosyl compounds 1a, 2a, 264 
and 3a were used for the polymeric compounds, to give methylcellulose 265 
derivatives 1b, 2b, and 3b. Figure 4 displays the 1H-NMR spectra of 266 
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methylcellulose derivatives 1b, 2b, and 3b acquired in D2O. Resonances 267 
corresponding to the peptide moieties at the methylcellulose ends are not clearly 268 
evident in their spectra because of the higher DP of the methylcellulose residues, 269 
compared to the cellobiosyl compounds 1a, 2a, and 3a, as shown in Figure 1. 270 
However, the triazole protons of compounds 2b and 3b appear at 8.42 and 8.43 271 
ppm, respectively, although those of compound 1a appear at 8.42, 8.35, and 8.27 272 
ppm. This fact indicates that compounds 2b and 3b are end-functionalized with 273 
peptide residues. The zeta potential of compounds 1b, 2b, and 3b summarized in 274 
Table 1 also indicate that the deprotections of compounds 2b and 3b were 275 
successful.  276 
 277 
Figure 4. 1H-NMR spectra of compounds 1b, 2b, and 3b in D2O. 278 
 279 
Figure 5 displays the FT-IR spectra of compounds 2b, 3b, 5b, 6b, 7b, 9, and 10. 280 
Infrared absorption peaks corresponding to the protected di(arginine) and 281 
di(glutamic acid) segments 9 and 10 appear in the spectra of methylcelluloses 5b 282 
17 
and 6b end-functionalized with the di(arginine), and di(glutamic acid) derivatives, 283 
respectively. The infrared absorption peak associated with methylcellulosyl azide 284 
7b was observed at 2116 cm-1. After the Huisgen 1,3-dipolar cycloaddition of 7b 285 
with the di(arginine) or di(glutamic acid) derivatives 9 or 10, infrared absorption 286 
peaks associated with the azido group were not evident in the spectra of 5b and 6b, 287 
which indicates that the Huisgen 1,3-dipolar cycloadditions were successful. The 288 
infrared spectra of compounds 5b and 6b changed during deprotection to give 2b 289 
and 3b. The infrared absorption peaks corresponding to Pbf and Fmoc groups of 290 
MC-b-(Arg(Pbf))2-Fmoc 5b were not evident in the spectrum of MC-b-ArgArg 2b. 291 
The infrared absorption peaks associated with the tBu and Fmoc groups of MC-b-292 
(Glu(OtBu))2-Fmoc 6b were not evident in the spectrum of MC-b-GluGlu 3b. The 293 
FT-IR analyses of the end-functionalized methylcellulose derivatives provide us 294 
with additional experimental data regarding the polymer reactions that occur at the 295 
ends of these macromolecules. We conclude that methylcelluloses 2b and 3b end-296 
functionalized with peptides were successfully synthesized. 297 
 298 
Figure 5. FT-IR spectra of compounds 2b, 3b, 5b, 6b, 7b, 9, and 10. 299 
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 300 
Physical properties of compounds 1b, 2b, and 3b 301 
Table 1 summarizes the structures, solution surface tensions, and zeta potentials 302 
of compounds 1b, 2b, and 3b, while Figure 6 shows the surface tensions of 303 
solutions of compounds 1b, 2b, and 3b as functions of concentration, measured at 304 
23 °C. Compounds 2b and 3b exhibited similar surface-tension curves; the critical 305 
micelle concentrations (CMCs) of the arginine-containing compound 2b and the 306 
glutamic-acid-containing compound 3b are both 0.0035 mg/mL, slightly lower 307 
than that of the cellobiose derivative 1b (0.008 mg/mL). An ionic peptide residue 308 
at the end of the methylcellulose unit improves its surface activity compared to 309 
that of methylcellulose end-functionalized with the nonionic cellobiosyl residue. 310 
In contrast, the CMCs of methylcelluloses 2b and 3b end-functionalized with 311 
peptides (0.0035 mg/mL) are clearly lower than that of commercial SM-4 312 
methylcellulose (0.1 mg/mL). 313 
Figure 6. Surface tensions of compounds 1b, (orange open squares), 2b (green open triangles), 314 




Table 1. Surface tensions and zeta potentials of compounds 1b, 2b, and 3b.  318 
 319 
Figure 7 displays the temperature-dependence of the supramolecular 320 
aggregation behavior of compounds 1b, 2b, and 3b in water, obtained by dynamic 321 
light scattering (DLS) experiments. The hydrodynamic diameters of compounds 322 
1b, 2b, and 3b at 25 °C were determined to be 138, 706, and 476 nm, respectively. 323 
Although the hydrodynamic diameter of commercial MC SM-4 gradually 324 
increased at temperatures above approximately 45 °C, those of compounds 1b, 2b, 325 


















MC 1.8 50.1 0.1
1b Cellobiose 20.7 2.65 49.0 0.008 
2b Arginine dimer 27.3 − 47.3 0.0035 
3b Glutamic acid dimer 32.8 − 49.3 0.0035 
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Figure 7. Hydrodynamic diameters of 0.2 wt% aqueous solutions of compounds 1b (orange solid 328 
squares), 2b (green solid triangles), 3b (purple solid circles), and commercial MC (black solid 329 
diamonds) as functions of temperature. 330 
 331 
Figure 8 shows the DSC thermograms of 2 wt% aqueous solutions of 332 
compounds 2b and 3b. Endothermic peaks appear at 31.5 °C and 32.6 °C for 333 
compounds 2b and 3b, respectively. The endothermic temperatures of compounds 334 
2b and 3b are closely related to the supramolecular aggregation temperatures 335 
determined by DLS. The endothermic peaks observed by DSC are attributed to 336 
dehydration around the peptide-end-functionalized MCs 2b and 3b. Dehydration 337 
around these cellulosic molecules promotes their supramolecular aggregation, as 338 
shown in Figure 7. 339 
 340 
21 
Figure 8. DSC thermograms of 2.0 wt% aqueous solutions of compounds 2b and 3b: (A) heating 341 
curves (3.5 °C/min) and (B) cooling curves (3.5 °C/min).  342 
 343 
Table 2 displays images of 2.0 and 4.0 wt% aqueous solutions of compounds 1b, 344 
2b, and 3b at 0 and 35 °C. The 2 wt% aqueous solution of the cellobiose-345 
functionalized MC 1b forms a hydrogel at 35 °C. In contrast, the peptide-346 
functionalized MCs 2b and 3b do not form hydrogels at 35 °C, rather their 347 
solutions became turbid at this temperature. In other words, the 2.0 wt% aqueous 348 
solutions of 2b and 3b phase separate at 35 °C. However, 4.0 wt% aqueous 349 
solutions of 1b, 2b, and 3b form hydrogels at 35 °C. The concentrations of the 350 
thermally induced supramolecular structures of 2b and 3b are the keys to forming 351 
thermo-reversible hydrogels because 4.0 wt% aqueous solutions of the peptide-352 




Table 2. Images of 2.0 and 4.0 wt% aqueous solutions of compounds 1b, 2b, and 3b. 356 
 357 
Figure 9. SEM images of the hydrogels of (a, b) 2b and (c, d) 3b. (e, f) TEM images of the 358 
hydrogel of 2b. Insets (b) and (d) are enlargements of regions in panels (a) and (c). 359 
 360 
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Lyophilized hydrogels from compounds 2b and 3b 361 
SEM images of lyophilized hydrogels of 2b and 3b are shown in Figures 9a–d. 362 
We previously reported that methylcellulose end-functionalized with cellobiose 363 
exhibits a layered structure (Yamagami et al. 2018). In contrast, the peptide-364 
functionalized methylcelluloses 2b and 3b form a three-dimensional mesh 365 
structure (2b) and a spongy, foam-like structure (3b), indicating that the 366 
hydrophilic segments at the ends of the methylcellulose units of the lyophilized 367 
hydrogels have different nanostructures.  368 
TEM images of the nanostructure of the thermoresponsive 369 
supramolecular hydrogel of 2b 370 
TEM images of the hydrogel of compound 2b are shown in Figures 9e–f, in 371 
which regular stick-like structures with orthogonal widths of approximately 12 nm 372 
and 15 nm, can be seen. The widths of the stick-like structures are constant, 373 
although their lengths vary widely. The molecular length of compound 2b is ~16 374 
nm, which suggests that the longer width of a single rectangular structure is likely 375 
to correspond to the molecular length of compound 2b. The average thickness of 376 
these structures was determined by atomic force microscopy to be approximately 377 
10 nm (data not shown). Rectangular self-assemblies appear to form stick-like 378 
structures, and their entanglements produce a macroscopic hydrogel.  379 
Drug release from thermoresponsive supramolecular hydrogel 380 
matrices 381 
 The thermo-reversible supramolecular hydrogels of MCs 2b and 3b end-382 
functionalized with cationic and anionic peptides, respectively, are expected to 383 
interact with anionic and cationic compounds, respectively. Therefore, we 384 
investigated the ionic drug-release behavior of these hydrogels. To that end, 385 
24 
diclofenac sodium and imipramine were selected as model anionic and cationic 386 
drugs, respectively.  387 
Figure 10 displays the drug-release behavior of the thermoresponsive 388 
supramolecular hydrogel matrices of 1b, 2b, and 3b. These matrices exhibit 389 
almost the same release behavior for diclofenac sodium (DFNa) at 37 °C at the 390 
start of release testing. Approximately 28–29% of the DFNa was released from 391 
hydrogel matrices 1b, 2b, and 3b after 1 h. After 12 h, ~81% of the DFNa was 392 
released from cationic hydrogel matrix 2b, while ~100% of the DFNa was 393 
released from the nonionic and anionic hydrogel matrices 1b and 3b. This 394 
observation indicates that the cationic di(arginine) segment at the end of the MC 395 
affects the release behavior of the anionic DFNa from the thermoresponsive 396 
supramolecular hydrogel matrix. 397 
In contrast, cationic imipramine interacts with anionic supramolecular hydrogel 398 
matrix 3b. At the beginning of imipramine-release testing (after 1 h of incubation) 399 
27%, 28%, and 22% of the imipramine was released from hydrogel matrices 1b, 400 
2b, and 3b, respectively. After 12 h, 98%, 96%, and 81% of the imipramine was 401 
released from hydrogel matrices 1b, 2b, and 3b, respectively, which indicates that 402 
the anionic di(glutamic acid) segment at the end of the MC interacts with the 403 
cationic imipramine. Ionic interactions between the cationic imipramine and the 404 
anionic hydrogel matrix 3b promote the relatively slow release of imipramine 405 
from the thermoresponsive supramolecular hydrogel matrix. 406 
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 407 
Figure 10. Drug-release behavior from the thermoresponsive supramolecular hydrogel matrices of 408 
1b (orange solid circles), 2b (green open circles), and 3b (purple open diamonds). 409 
 410 
To gain deep insight into the interaction between the model drugs and the MCs 411 
end-functionalized with peptides, we performed 1H-NMR experiments involving 412 
DFNa, methylated cellobiose derivative 2a (a model compound of the MC end-413 
functionalized with di(arginine) 2b), and a mixture of DFNa and 2a, in deuterium 414 
oxide.  415 
Figure 11 reveals changes in the chemical shifts corresponding to both 416 
compounds, namely DFNa and 2a, following mixing. After mixing anionic DFNa 417 
and cationic 2a in D2O, the proton resonances of DFNa, numbered 1 to 8, were 418 
observed to shift downfield by 0.007, 0.010, 0.020, 0.033, 0.019, 0.019, 0.019, 419 
and 0.009 ppm, respectively, which indicates that all of the protons in DFNa 420 
became deshielded through the removal of electron density. In contrast, the 421 
methylene protons of the arginine side-chain appear at higher magnetic fields 422 
following mixing, which indicate that these protons have became shielded due to 423 
an increase in electron density. In addition, the triazole proton of 2a, which 424 
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resonated at 8.19 ppm prior to mixing, also appeared at slightly higher magnetic 425 
field following mixing with DFNa. 426 
These observations indicate that supramolecular hydrogels of methylcellulose 427 
end-functionalized with ionic peptides are expected to not only be 428 
thermoresponsive but also pH responsive. This temperature/pH dual-429 
responsivenesses of compounds 2b and 3b are currently under investigation. 430 
 431 
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Figure 11. 1H-NMR analyses of the interactions between compound 2b and diclofenac sodium.  432 
 433 
28 
Figure 12. Inhibition of U937 cell growth by compounds 1b, 2b, and 3b. 434 
 435 
Cytotoxicities of compounds 1b, 2b, and 3b 436 
ATP-based U937 histocytoma cell-viability assays reveal that the half maximal 437 
inhibitory concentrations (IC50 values) of compounds 1b, 2b, and 3b were 470, 438 
560, and 600 µg/mL, respectively, as shown in Figure 12. As previously noted, 4 439 
wt% aqueous solutions (40 mg/mL) of compounds 2b and 2c become 440 
supramolecular thermoresponsive hydrogels at 37 °C (see Table 2). The 441 
hydrogelation of an aqueous solution of compound 2b or 2c is likely to inhibit cell 442 
growth of suspension-type cells such as U937. However, the cytotoxicities of 443 
aqueous solutions of compounds 2b and 2c, determined by IC50 values, have been 444 
evaluated correctly, despite some supramolecular structures potentially present in 445 
the aqueous solutions. In summary, methylcelluloses end-functionalized with 446 
peptides are essentially nontoxic to U937 histocytoma cells because IC50 values of 447 
0.6 wt% are considerably high. 448 
 449 
Conclusion 450 
Aqueous solutions of methylcelluloses end-functionalized with peptides exhibit 451 
supramolecular thermoresponsive hydrogelation behavior equivalent to those of 452 
block-functionalization methylcelluloses (Nakagawa et al. 2011a; Nakagawa et al. 453 
2012c; Yamagami et al. 2018). The tri-O-methylcellulose block, as a hydrophobic 454 
segment (Kamitakahara et al. 2016), is a key structure for supramolecular 455 
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thermoresponsive hydrogelation. Investigation into the relationships between the 456 
anomeric configuration at the reducing-end of the tri-O-methylcellulose block and 457 
physico-chemical properties in solution is now in progress. We were able to not 458 
only introduce carbohydrates (Yamagami et al. 2018) but also peptides as 459 
hydrophilic segments at the ends of hydrophobic tri-O-methylcellulose units, 460 
resulting in the syntheses of a pool of diblock methylcellulose analogues with 461 
biological functions that retain thermoresponsive hydrogelation behavior at 462 
human-body temperature. As methylcellulose is produced from cellulose, which is 463 
a natural resource, methylcelluloses end-functionalized with peptides are expected 464 
to be used in biomedical applications as, for example, comparatively safe 465 
injectable hydrogels. 466 
 467 
Experimental Section 468 
Materials.  469 
Nα-(9-Fluorenylmethoxycarbonyl)-Nω-(2,2,4,6,7-470 
pentamethyldihydrobenzofuran-5-sulfonyl)-L-arginine (Nα-Fmoc-Nω-Pbf-L-471 
arginine) was purchased from Watanabe Chemical Industries, Ltd., Japan. Nα-(9-472 
Fluorenylmethoxycarbonyl)glutamic acid γ-tert-butyl ester monohydrate (Fmoc-473 
Glu(Ot-Bu)-OH) was purchased from Peptide Institute, Inc., Japan. Other 474 
chemicals were purchased from Nacalai Tesque, Wako Pure Chemicals, Tokyo 475 
Chemical Industry, and Sigma-Aldrich. All reagents and solvents were of 476 
commercial grade and were used without further purification. 477 
Synthesis.  478 
Nα-Fmoc-Nω-Pbf-L-arginine-N-propargylamide (12) 479 
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Nα-Fmoc-Nω-Pbf-L-arginine-N-propargylamide (12) (Yang et al. 2011) was 480 
prepared from Nα-Fmoc-Nω-Pbf-L-arginine (11) (89% yield). Briefly, to a 481 
solution of Nα-Fmoc-Nω-Pbf-L-arginine (11, 200 mg) in methanol (5 mL) was 482 
added propargylamine (19 µL) and 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-483 
methylmorpholinium chloride (DMT-MM, 102 mg). The reaction mixture was 484 
stirred for 3 h under nitrogen. The crude product was purified by preparative 485 
silica-gel thin-layer chromatography (PTLC, eluent: 10% MeOH/CH2Cl2) to give 486 
compound 12 (188 mg, 89% yield). 487 
1H-NMR (500 MHz, CDCl3): δ 1.42 (6H, CH3, Pbf), 1.55-1.58 (m, 2H, Hγ), 488 
1.85 (m, 2H, Hβ), 2.07 (s, 3H, CH3, Pbf), 2.14 (t, 1H, J=2.0 Hz, CH2CCH), 2.50 489 
(s, 3H, CH3, Pbf), 2.57 (s, 3H, CH3, Pbf), 2.91 (s, 2H, CH2, Pbf), 3.28 (m, 2H, Hδ), 490 
3.98 (m, 2H, CH2CCH), 4.14 (t, 1H, J=7.0 Hz, CH, Fmoc), 4.27 (m, 1H, Hα), 491 
4.34 (d, 2H, J=7.0 Hz, Fmoc), 7.24-7.74 (arom. Fmoc) 492 
13C-NMR (125 MHz, CDCl3): δ 12.4 (CH3, Pbf), 17.9 (CH3, Pbf), 19.3 (CH3, 493 
Pbf), 25.2 (Cγ), 28.5 (CH3, Pbf), 29.1 (CH2CCH), 30.1 (Cβ), 40.5 (Cδ), 43.1 (CH2, 494 
Pbf), 46.9 (CH, Fmoc), 54.1 (Cα), 67.1 (CH2, Fmoc), 71.3 (CH2CCH), 79.4 495 
(CH2CCH), 86.4 (C, Pbf), 117.5 (arom. Pbf), 119.9 (arom. Fmoc), 124.7 (arom. 496 
Pbf), 125.1 (arom. Fmoc), 127.0 (arom. Fmoc), 127.7 (arom. Fmoc), 132.3 (arom. 497 
Pbf), 138.4 (arom. Pbf), 141.1 (arom. Fmoc), 143.6 (arom. Fmoc), 143.7 (arom. 498 
Fmoc), 156.3, 156.6 (CO Fmoc, quaternary C of guanidino group of arginine), 499 
158.9 (-O-C arom. Pbf), 172.1 (Arg, Cα-CO-NH-) 500 
Nω-Pbf-L-arginine-N-propargylamide (13) 501 
Nα-Fmoc-Nω-Pbf-L-arginine-N-propargylamide (12, 200 mg) was dissolved in 502 
50% piperidine/dichloromethane (2 mL). The reaction mixture was stirred for 1 h 503 
at room temperature under nitrogen, after which it was concentrated to dryness. 504 
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The crude product was extracted with ethyl acetate, washed with water and brine, 505 
dried over sodium sulfate, and concentrated to dryness. The residue was purified 506 
by silica-gel column chromatography (eluent: 15% methanol/dichloromethane, 507 
v/v) to afford compound 13 (111 mg, 82% yield). 508 
1H-NMR (500 MHz, CDCl3): δ 1.47 (6H, CH3, Pbf), 1.56-1.63 (m, 2H, Hγ), 509 
1.80 (m, 2H, Hβ), 2.09 (s, 3H, CH3, Pbf), 2.22 (t, 1H, J=2.0 Hz, CH2CCH), 2.50 510 
(s, 3H, CH3, Pbf), 2.57 (s, 3H, CH3, Pbf), 2.96 (s, 2H, CH2, Pbf), 3.22 (m, 2H, Hδ), 511 
3.45 (t, 1H, Hα), 3.98 (m, 2H, CH2CCH),  512 
13C-NMR (125 MHz, CDCl3): δ 12.4 (CH3, Pbf), 17.9 (CH3, Pbf), 19.3 (CH3, 513 
Pbf), 25.4 (Cγ), 28.5 (CH3, Pbf), 28.8 (CH2CCH), 31.9 (Cβ), 40.6 (Cδ), 43.2 (CH2, 514 
Pbf), 54.2 (Cα), 71.3 (CH2CCH), 79.6 (CH2CCH), 86.4 (C, Pbf), 117.5 (arom. 515 
Pbf), 124.6 (arom. Pbf), 132.2 (arom. Pbf), 138.2 (arom. Pbf), 156.4 (quaternary 516 
C of guanidino group of arginine), 158.9 (-O-C arom. Pbf), 175.1 (Arg, Cα-CO-517 
NH-) 518 
Nα-Fmoc-Nω-Pbf-L-arginine-Nω-Pbf-L-arginine-N-propargylamide (9) 519 
(Morelli and Matile 2017) 520 
To a solution of Nα-Fmoc-Nω-Pbf-L-arginine (11, 101 mg, 1.2 equiv.) and Nω-521 
Pbf-L-arginine-N-propargylamide (13, 60 mg, 1.0 equiv.) in methanol (5 mL) was 522 
added DMT-MM (43 mg, 1.2 equiv.). The reaction mixture was stirred for 4 h at 523 
room temperature under nitrogen, and then concentrated to dryness. The crude 524 
product was purified by PTLC (eluent: 10% methanol/dichloromethane) to afford 525 
compound 9 as colorless crystals (126 mg, 89% yield). 526 
1H-NMR (500 MHz, CDCl3): δ 1.42 (12H, CH3, Pbf), 1.63 (m, 4H, Hγ), 1.78 527 
(m, 2H, Hβ), 1.92 (m, 2H, Hβ), 2.05 (s, 3H, CH3, Pbf), 2.06 (s, 3H, CH3, Pbf), 528 
2.09 (1H, CH2CCH), 2.48 (s, 3H, CH3, Pbf), 2.49 (s, 3H, CH3, Pbf), 2.55 (s, 3H, 529 
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CH3, Pbf), 2.57 (s, 3H, CH3, Pbf), 2.90 (s, 2H, CH2, Pbf), 2.91 (s, 2H, CH2, Pbf), 530 
3.21 (m, 4H, Hδ), 3.91-3.96 (m, 2H, CH2CCH), 4.09 (t, 1H, J=7.0 Hz, CH, Fmoc), 531 
4.27 (broad t, 1H, Hα), 4.32-4.36 (d, d, 1H, 1H, J=7.0 Hz, Fmoc), 7.17-7.73 532 
(arom. Fmoc) 533 
13C-NMR (125 MHz, CDCl3): δ 12.4 (CH3, Pbf), 17.9 (CH3, Pbf), 19.3 (CH3, 534 
Pbf), 25.6 (Cγ), 28.5 (CH3, Pbf), 29.1 (CH2CCH), 29.1 (Cβ), 40.0 (Cδ), 40.6 (Cδ), 535 
43.1 (CH2, Pbf), 46.9 (CH, Fmoc), 53.5 (Cα), 55.1 (Cα), 67.3 (CH2, Fmoc), 71.3 536 
(CH2CCH), 79.4 (CH2CCH), 86.4 (CH, Fmoc), 117.6 (arom. Pbf), 119.9 (arom. 537 
Fmoc), 124.7 (arom. Pbf), 125.1 (arom. Fmoc), 127.0 (arom. Fmoc), 127.7 (arom. 538 
Fmoc), 132.3 (arom. Pbf), 138.4 (arom. Pbf), 141.1 (arom. Fmoc), 143.7 (arom. 539 
Fmoc), 156.4, 157.0 (CO Fmoc, quaternary C of guanidino group of arginine), 540 
158.9 (-O-C arom. Pbf), 172.0 (Arg, Cα-CO-NH-), 173.4 (Arg, Cα-CO-NH-) 541 
MALDI-TOF MS (m/z): calcd for C56H73N9O10S2, 1095.49; found, [M+Na]+ = 542 
1116.2 543 
FT-IR (KBr): 3440, 3338, 2970, 2934, 1670, 1618, 1551, 1450, 1369, 1248, 1155, 544 
1105, 853, 806, 783, 760, 741 (Fmoc), 669, 642, 621, 569 (Pbf, -SO2NH-) cm-1 545 
 546 
Fmoc-Glu(Ot-Bu)-N-propargylamide (15) (Aagren et al. 2006) 547 
To a solution of Fmoc-Glu(Ot-Bu)-OH (14, 300 mg) in methanol (5 mL) was 548 
added propargylamine (52 µL) and DMT-MM (102 mg). The reaction mixture 549 
was stirred for 3 h under nitrogen. The crude product was purified by PTLC 550 
(eluent: 10% MeOH/CH2Cl2) to give compound 15 as colorless crystals (324 mg, 551 
quantitative yield). 552 
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1H-NMR (500 MHz, CDCl3): δ 1.47 (s, 9H, CH3, tBu), 1.96 (m, 1H, Hβ), 2.09 553 
(m, 1H, Hβ), 2.22 (t, 1H, J=2.0 Hz, CH2CCH), 2.33 (m, 1H, Hγ), 2.43 (m, 1H, 554 
Hγ), 4.05 (broad s, 2H, CH2CCH), 4.21 (2H, CH Fmoc, Hα), 4.41 (m, 2H, Fmoc), 555 
5.78 (d, 1H, J=7.5 Hz, NH), 6.70 (broad s, 1H, NH), 7.32 (dt, 2H, J=1.0 Hz, J=7.5 556 
Hz, Fmoc), 7.32 (dt, 2H, J=1.0 Hz, J=1.0 Hz, Fmoc), 7.41 (dt, 2H, J=1.0 Hz, 557 
Fmoc), 7.77 (d, 2H, J=7.5 Hz, Fmoc),  558 
13C-NMR (125 MHz, CDCl3): δ 28.0 (CH2CCH), 28.0 (CH3, tBu), 39.2 (Cβ), 559 
31.6 (Cγ), 47.1 (CH, Fmoc), 54.1 (Cα), 67.1 (CH2, Fmoc), 71.8 (CH2CCH), 79.1 560 
(CH2CCH), 81.2 (quaternary C of tBu), 120.0 (arom. Fmoc), 125.0 (arom. Fmoc), 561 
127.1 (arom. Fmoc), 127.7 (arom. Fmoc), 141.3 (arom. Fmoc), 143.7 (arom. 562 
Fmoc), 156.3 (CO Fmoc), 171.0 (Glu, -Cα-CO-NH-), 173.0 (Glu, CδOO tBu) 563 
MALDI-TOF MS (m/z): calcd for C27H30N2O5, 462.22; found, [M+Na]+ = 485.2, 564 
[M+K]+ = 501.2 565 
 566 
Glu(Ot-Bu)-N-propargylamide (16) (Aagren et al. 2006) 567 
Fmoc-Glu(Ot-Bu)-N-propargylamide (15, 308 mg) was dissolved in 50% 568 
piperidine/dichloromethane (2 mL). The reaction mixture was stirred for 1 h at 569 
room temperature under nitrogen, after which it was concentrated to dryness. The 570 
crude product was extracted with ethyl acetate, washed with water and brine, 571 
dried over sodium sulfate, and concentrated to dryness. The residue was purified 572 
by silica-gel column chromatography (eluent: dichloromethane; eluent: 5% 573 
methanol/dichloromethane, v/v) to afford compound 16 (166 mg, quantitative 574 
yield). 575 
1H-NMR (500 MHz, CDCl3): δ 1.45 (s, 9H, CH3 (tBu)), 1.83 (m, 1H, Hβ), 2.09 576 
(m, 1H, Hβ), 2.23 (t, 1H, J=2.0 Hz, CH2CCH), 2.35 (m, 2H, Hγ), 3.44 (t, 1H, Hα), 577 
4.05 (broad s, 2H, CH2CCH), 578 
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13C-NMR (125 MHz, CDCl3): δ 28.0 (CH3 (tBu)), 28.8 (CH2CCH), 30.1 (Cβ), 579 
31.9 (Cγ), 54.4 (Cα), 71.4 (CH2CCH), 79.6 (CH2CCH), 80.7 (C(CH3)3), 172.8 580 
(Glu, -Cα-CO-NH-), 174.1 (Glu, CδOO tBu) 581 
MALDI-TOF MS (m/z): calcd for C12H20N2O3, 240.15; found, [M+Na]+ = 263.9 582 
 583 
Nα-Fmoc-Glu(Ot-Bu)-Glu(Ot-Bu)-N-propargylamide (10) 584 
To a solution of Fmoc-Glu(Ot-Bu)-OH (14, 328 mg, 1.2 equiv.) and Glu(Ot-585 
Bu)-N-propargylamide (16, 148 mg, 1.0 equiv.) in methanol (5 mL) was added 586 
DMT-MM (204 mg, 1.2 equiv.). The reaction mixture was stirred for 1 h at room 587 
temperature under nitrogen, and then concentrated to dryness. The crude product 588 
was purified by PTLC (eluent: 5% methanol/dichloromethane) to afford 589 
compound 10 as colorless crystals (378 mg, 95% yield). 590 
1H-NMR (500 MHz, CDCl3): δ 1.43 (s, 9H, CH3 (tBu)), 1.47 (s, 9H, CH3 (tBu)), 591 
1.96-2.15 (m, 4H, Hβ), 2.13 ((t, 1H, J=2.0 Hz, CH2CCH), 2.33-2.47 (m, 4H, Hγ), 592 
3.96-4.03 (broad s, 2H, CH2CCH), 4.20 (1H, H (Fmoc)), 4.20-4.24 (1H, Hα), 593 
4.38-4.44 (m, 2H, CH2 (Fmoc)), 4.48-4.49 (m, 1H, Hα), 7.30-7.77 (8H, arom. 594 
Fmoc) 595 
13C-NMR (125 MHz, CDCl3): δ 27.0 (Cβ'), 27.4 (Cβ), 28.0 (CH3 (tBu)), 29.1 596 
(CH2CCH), 30.1 31.7 (Cγ'), 31.8 (Cγ), 52.6 (Cα'), 55.2 (Cα), 67.3 (CH2, Fmoc), 597 
71.3 (CH2CCH), 79.4 (CH2CCH), 81.1 (C(CH3)3), 81.3 (C(CH3)3), 120.0, 125.1, 598 
127.0, 127.7, 141.2, 143.7, 156.5, 170.6 (Glu, -Cα-CO-NH-), 171.6 (Glu, -Cα-599 
CO-NH-), 173.0 (Glu, CδOO tBu), 173.2 (Glu, CδOO tBu) 600 
MALDI-TOF MS (m/z): calcd for C36H45N3O8, 647.32; found, [M+Na]+ = 670.4 601 
FT-IR (KBr): 3290, 2978, 1728, 1694, 1639, 1537 (tBu), 1450, 1368, 1258, 602 




glucopyranosyl azide (7a) 606 
A 60% suspension of sodium hydride in mineral oil (1.97 g, 82.1 mmol, 14.0 607 
equiv.) was added to a solution of β-D-glucopyranosyl-(1→4)-β-D-glucopyranosyl 608 
azide (Schamann and Schafer 2003; Ying and Gervay-Hague 2003) (1.29 g, 3.51 609 
mmol) in DMF (30 mL) at 0 °C. The mixture was stirred at 0 °C for 1 h under 610 
nitrogen. Methyl iodide (3.1 mL, 49.8 mmol, 14.2 equiv.) was then added to the 611 
reaction mixture at 0 °C. After 2 h, the mixture was warmed to room temperature 612 
and stirred for 2 h. The reaction was monitored by analytical thin-layer 613 
chromatography (TLC). Methanol (0.43 mL) was added to deactivate the sodium 614 
hydride. The mixture was concentrated and the crude product was extracted with 615 
ethyl acetate, washed with distilled water, brine, dried over Na2SO4, and 616 
concentrated to dryness. The residue was purified by silica-gel column 617 
chromatography (eluent: 2:1 (v/v) ethyl acetate/n-hexane) to give colorless 618 
crystals (7a, 0.799 g, 49% yield). 619 
1H-NMR (500 MHz, CDCl3): δ 2.86 (dd, 1H, J=8.0 Hz, J=8.5 Hz, H2'), 1H, 620 
2.90 (t, 1H, J=9.0 Hz, H3'), 3.06 (t, 1H, J=9.5 Hz, H3'), 3.12 (t, 1H, J=9.5 Hz, 621 
H4'), 3.16 (ddd, 1H, J=2.0 Hz, J=4.0 Hz, J=9.5 Hz, H5'), 3.19 (t, 1H, J=9.0 Hz, 622 
H3), 3.32 (s, 3H, OCH3), 3.34 (s, 3H, OCH3), 3.36 (ddd, 1H, J=2.0 Hz, J=4.0 Hz, 623 
J=10.0 Hz, H5), 3.46 (s, 3H, OCH3), 3.48 (s, 3H, OCH3), 3.52 (dd, 1H, J=4.0 Hz, 624 
J=11.0 Hz, H6), 3.53 (s, 6H, OCH3), 3.56 (s, 3H, OCH3), 3.56 (dd, 1H, J=2.0 Hz, 625 
J=10.5 Hz, H6'), 3.62 (dd, 1H, J=9.0 Hz, J=10.0 Hz, H4), 3.63 (dd, 1H, J=2.0 Hz, 626 
J=11.0 Hz, H6), 3.67 (dd, 1H, J=4.0 Hz, J=11.0 Hz, H6), 4.23 (d, 1H, J=7.5 Hz, 627 
H1'), 4.40 (d, 1H, J=8.5 Hz, H1) 628 
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13C-NMR (125 MHz, CDCl3): δ 103.2 (C1'), 89.9 (C1), 86.9 (C3'), 84.9 (C3), 629 
84.0 (C2'), 82.8 (C2), 79.3 (C4'), 77.2 (C4), 76.9 (C5), 74.7 (C5'), 71.2 (C6'), 70.1 630 
(C6), 60.8, 60.6, 60.6, 60.6, 60.3, 59.3, 59.2 (OCH3)  631 
 632 
Tri-O-methylcellulosyl azide (7b) Compound 7b was prepared according to our 633 
previous paper (Kamitakahara et al. 2016).  634 
FT-IR (KBr): 3478, 2926, 2836, 2116 (N3), 1458, 1375, 1314, 1182, 1061, 949, 635 
664 cm-1 636 
 637 
2-Propynyl 2,3,6-tri-O-acetyl-β-D-glucopyranosyl-(1→4)-2,3,6-tri-O-acetyl-638 
β-D-glucopyranoside (8) Compound 8 was prepared according to our previous 639 




tri-O-acetyl-β-D-glucopyranosyloxymethyl]-1H-1,2,3-triazole (4a)  644 
Azide 7a (117 mg, 0.252 mmol) and glycoside 8 (170 mg, 0.252 mmol) were 645 
dissolved in DMF (9 mL). Copper(I) bromide (361.5 mg, 2.52 mmol, 10 equiv.), 646 
sodium ascorbate in water (998.5 mg/1.26 mL, 20 equiv.), and N,N,N',N'',N''-647 
pentamethyldiethylenetriamine (PMDETA, MW = 173.3, d = 0.83 g/mL, 0.5 mL, 648 
10 equiv.) were added to the solution at room temperature. The reaction mixture 649 
was stirred for 21 h. The insoluble component was then removed by filtration and 650 
washed with dichloromethane. The washings and filtrate were combined and 651 
concentrated, and the DMF was azeotropically removed with ethanol. The crude 652 
product was purified by silica-gel column chromatography (eluent: 10% 653 
37 
MeOH/CH2Cl2) to give 1-[2,3,4,6-tetra-O-methyl-β-D-glucopyranosyl-(1→4)-654 
2,3,6-tri-O-methyl-β-D-glucopyranosyl]-4-[2,3,4,6-tetra-O-acetyl-β-D-655 
glucopyranosyl-(1→4)-2,3,6-tri-O-acetyl-β-D-glucopyranosyloxymethyl]-1H-656 
1,2,3-triazole (4a, 161.3 mg, 56% yield). 657 
1H-NMR (500 MHz, CDCl3): δ 1.97, 1.99, 2.01, 2.01, 2.04, 2.09, 2.15 (COCH3), 658 
2.95 (t, 1H, J=8.5 Hz, H2’Me), 3.15 (t, 1H, J=9.0 Hz, H3’Me), 3.19 (s, 3H, OCH3), 659 
3.21 (t, 1H, J=9.0 Hz, H4’Me), 3.26 (ddd, 1H, J=2 Hz, J=3.5 Hz, J=9.5 Hz, H5’Me), 660 
3.33 (s, 3H, OCH3), 3.43 (s, 3H, OCH3), 3.44 (t, 1H, J=9.0 Hz, H3Me), 3.55 (s, 3H, 661 
OCH3), 3.57 (s, 3H, OCH3), 3.64 (s, 6H, OCH3), 3.6-3.7 (H6’Me, H2Me, H5Me, H5Ac, 662 
H5’Ac), 3.75 (dd, 1H, J=4.0 Hz, J=11.0 Hz, H6Me), 3.79 (t, 1H, J=9.5 Hz, H4Ac), 663 
3.82 (dd, 1H, J=9.0 Hz, J=10.0 Hz, H4Me), 4.05 (dd, 1H, J=2.5 Hz, J=12.5 Hz, 664 
H6Ac), 4.11 (dd, 1H, J=5.0 Hz, J=12.0 Hz, H6’Ac), 4.34 (d, 1H, J=8.0 Hz, H1’Me), 665 
4.36 (dd, 1H, J=4.0 Hz, J=12.0 Hz, H6Ac), 4.52 (d, 1H, J=8.0 Hz, H1’Ac), 4.56 (dd, 666 
1H, J=2.0 Hz, J=12.0 Hz, H6’Ac), 4.62 (d, 1H, J=8.0 Hz, H1Ac), 4.81 (d, 1H, 667 
J=13.0 Hz, OCH2-triazole), 4.92 (d, 1H, J=13.0 Hz, OCH2-triazole), 4.9-4.95 668 
(H2Ac, H2’Ac), 5.07 (t, 1H, J=9.5 Hz, H4’Ac), 5.15 (t, 1H, J=9.0 Hz, H3Ac) , 5.15 (t, 669 
1H, J=9.0 Hz, H3’Ac), 5.47 (d, 1H, J=9.5 Hz, H1Me), 7.69 (s, 1H, triazole) 670 
13C-NMR (125 MHz, CDCl3): δ 20.5, 20.6, 20.6, 20.9 (COCH3), 59.0 (OCH3), 671 
59.4 (OCH3), 60.3 (OCH3), 60.4 (OCH3), 60.7 (OCH3), 60.7 (OCH3), 60.8 672 
(OCH3), 61.5(C6’Ac), 61.7 (C6Ac), 62.8 (OCH2-triazole), 67.8 (C4’Ac), 70.0 (C6Me), 673 
71.2 (C6’Me), 71.4 (C2Ac or C2’Ac), 71.6 (C2Ac or C2’Ac), 72.0 (C5Ac), 72.4 (C5’Ac), 674 
72.8 (C3Ac or C3’Ac), 72.9 (C3Ac or C3’Ac), 74.8 (C5’Me), 76.3(C4Ac), 77.9 (C4Me), 675 
79.3 (C4’Me), 82.1 (C2Me), 84.0 (C2’Me), 85.2 (C3Me), 87.0 (C3’Me), 87.3 (C1Me), 676 
99.6 (C1Ac), 100.7 (C1’Ac), 103.3 (C1’Me), 122.0 (triazole CH), 144.3 (O-CH2-C=), 677 




glucopyranosyloxymethyl]-1H-1,2,3-triazole (1a)  681 
Sodium methoxide (28%) in methanol (0.01 mL, 1.4 equiv.) was added at room 682 
temperature to a solution of 1-[2,3,4,6-tetra-O-methyl-β-D-glucopyranosyl-683 
(1→4)-2,3,6-tri-O-methyl-β-D-glucopyranosyl]-4-[2,3,4,6-tetra-O-acetyl-β-D-684 
glucopyranosyl-(1→4)-2,3,6-tri-O-acetyl-β-D-glucopyranosyloxymethyl]-1H-685 
1,2,3-triazole (4a, 146 mg, 0.128 mmol) in MeOH (1 mL) and THF (1 mL). The 686 
mixture was stirred for 3 h at room temperature. The solution was neutralized with 687 
Amberlyst H+. The Amberlyst H+ was removed by filtration and washed with 688 
MeOH. The combined filtrate and washings were concentrated to dryness to give 689 
1-[2,3,4,6-tetra-O-methyl-β-D-glucopyranosyl-(1→4)-2,3,6-tri-O-methyl-β-D-690 
glucopyranosyl]-4-[β-D-glucopyranosyl-(1→4)-β-D-glucopyranosyloxymethyl]-691 
1H-1,2,3-triazole (1a, 108.3 mg, quantitative yield). 692 
1H-NMR (500 MHz, D2O): δ 3.01 (t, 1H, J=9.5 Hz, H2’Me), 3.03 (s, 3H, OCH3), 693 
3.18 (t, 1H, J=10.0 Hz, H4’Me), 3.21 (H2OH), 3.21 (H2’OH), 3.25 (t, 1H, J=10.0 Hz, 694 
H3’Me), 3.25 (s, 3H, OCH3), 3.28 (H4’OH), 3.31 (s, 3H, OCH3), 3.33-3.38 (m, 1H, 695 
H5OH), 3.36 (t, 1H, J=9.0 Hz, H3’OH), 3.38 (H5’Me), 3.43 (s, 3H, OCH3), 3.49 (s, 696 
3H, OCH3), 3.5 (H3OH), 3.50-3.56 (H4OH), 3.52 (s, 6H, OCH3), 3.56-3.7 (H6Me and 697 
H6’Me), 3.58-3.86 (H6OH and H6’OH), 3.62 (H3Me), 3.73 (t, 1H, J=9.0 Hz, H2Me), 698 
3.79 (t, 1H, J=10.0 Hz, H4Me), 3.86 (m, 1H, H5Me), 4.33 (d, 1H, J=8.0 Hz, H1’Me), 699 
4.38 (d, 1H, J=8.5 Hz, H1’OH), 4.46 (d, 1H, J=7.5 Hz, H1OH), 4.81 (d, 1H, J=13.0 700 
Hz, OCH2-triazole), 4.90 (d, 1H, J=13.0 Hz, OCH2-triazole), 5.68 (d, 1H, J=9.0 701 
Hz, H1Me), 8.24 (s, 1H, triazole CH) 702 
39 
13C-NMR (125 MHz, D2O): δ 61.0 (OCH3), 61.1 (OCH3), 62.3 (OCH3), 62.6 703 
(OCH3), 62.6 (C6OH or C6’OH), 62.7 (OCH3), 63.2 (OCH3), 63.2 (C6OH or C6’OH), 704 
64.6 (OCH2-triazole), 72.1 (C4’OH), 72.4 (C6Me or C6’Me), 73.1 (C6Me or C6’Me), 705 
75.4 (C2’OH), 75.8 (C2OH), 76.1 (C3’OH), 76.9 (C3OH), 77.4 (C5OH), 78.1 (C5OH or 706 
C5’Me), 78.6 (C4Me), 78.7 (C5OH or C5’Me), 79.3 (C5Me), 81.1 (C4OH), 81.4 (C4’Me), 707 
83.9 (C2Me), 85.4 (C2’Me), 86.0 (C3Me), 87.6 (C3’Me), 88.9 (C1Me), 104.1 (C1OH), 708 
105.1 (C1’Me), 105.2 (C1’OH), 127.5 (triazole CH), 146.9 (O-CH2-C=) 709 
MALDI-TOF MS (m/z): calcd for C34H59N3O21, 845.36; found, [M+Na]+ = 710 




1,2,3-triazole (4b) 715 
Compound 4b was prepared according to our previous paper (Yamagami et al. 716 
2018). GPC analysis: Mn = 7.4 × 103, Mw / Mn = 1.4, DPn = 34.8. 717 
 718 
1-(2,3,6-Tri-O-methyl-cellulosyl)-4-[β-D-glucopyranosyl-(1→4)-β-D-719 
glucopyranosyloxymethyl]-1H-1,2,3-triazole (1b) 720 
Compound 1b was prepared according to our previous paper (Yamagami et al. 721 




methyl)-1H-1,2,3-triazole (5a) 726 
40 
To a solution of 2,3,4,6-tetra-O-methyl-β-D-glucopyranosyl-(1→4)-2,3,6-tri-O-727 
methyl-β-D-glucopyranosyl azide (7a, 25 mg, 0.054 mmol) and Fmoc-Arg(Pbf)-728 
Arg(Pbf)-NH-CH2CCH (9, 59 mg, 0.054 mmol) in 3 mL of 729 
methanol/dichloromethane (1/4, v/v) were added CuBr (77 mg, 0.054 mmol, 10 730 
equiv.) and aqueous sodium ascorbate (213 mg/269 µL). The reaction mixture 731 
was stirred under nitrogen at room temperature for 2 h. The mixture was purified 732 
by preparative TLC (eluent: 1:9 (v/v) methanol/dichloromethane) to give 1-733 
[2,3,4,6-tetra-O-methyl-β-D-glucopyranosyl-(1→4)-2,3,6-tri-O-methyl-β-D-734 
glucopyranosyl]-4-(Nα-Fmoc-Nω-Pbf-L-arginine-Nω-Pbf-L-arginine-N-methyl)-735 
1H-1,2,3-triazole (5a, 71 mg, 0.045 mmol, 85% yield). 736 
1H-NMR (500 MHz, CDCl3): δ: 1.44 (CH3, Pbf), 1.59 (Hγ), 1.85 (Hβ), 2.06-737 
2.09 (CH3, Pbf), 2.49-2.59 (CH3, Pbf), 2.92 (CH2, Pbf), 2.94 (CH2, Pbf), 2.92 (t, 738 
1H, J=9.0 Hz, H2’Me), 3.11 (OCH3), (3.12 (t, 1H, J=9.0 Hz, H3’Me), 3.15 (t, 1H, 739 
J=9.0 Hz, H4’Me), 3.21-3.25 (m, 1H, H5’Me), 3.22 (OCH3), 3.26 (Hδ), 3.40 (OCH3), 740 
3.35 (t, 1H, J=8.5 Hz, H3Me), 3.38 (OCH3), 3.52 (OCH3), 3.53 (OCH3), 3.59 741 
(OCH3), 3.62 (OCH3), 3.5-3.7 (H6’Me, H2Me, H5Me), 3.6-3.75 (2H, H6Me), 3.75 (t, 742 
1H, J=9.5 Hz, H4Me), 4.1-4.35 (broad s, Hα), 4.18-4.24 (1H, H (Fmoc)), 4.30 743 
(H1'Me), 4.32-4.36 (CH2, Fmoc), 4.43-4.60 (broad d, broad d, 2H, NH-CH2-744 
triazole), 5.41 (H1Me), 5.60 (NH), 6.0-6.6 (NH), 7.2-7.8 (arom. H, Fmoc)  745 
13C-NMR (125 MHz, CDCl3): δ 12.5 (CH3, Pbf), 17.9 (CH3, Pbf), 19.3 (CH3, 746 
Pbf), 25.6 (Cγ), 28.6 (CH3, Pbf), 29.7 (Cβ), 40.8 (Cδ), 43.2 (CH2, Pbf), 47.0 (CH, 747 
Fmoc), 53.6 (Cα), 54.4 (Cα), 58.7, 59.3, 60.4, 60.6, 60.8 (OCH3), 67.3 (CH2, 748 
Fmoc), 70.1 (C6), 71.2 (C6'), 74.7 (C5'), 77.2 (C4), 77.4 (C5), 79.3 (C4'), 81.8 749 
(C2), 84.0 (C2'), 85.2 (C3), 86.4 (CH, Fmoc), 86.4 (CH, Fmoc), 86.9 (C3'), 87.0 750 
(C1), 103.3 (C1'), 117.6 (arom. Pbf), 119.9 (arom. Fmoc), 120.0, 122.5 (triazole 751 
41 
CH), 124.6 (arom. Pbf), 124.9 (arom. Fmoc), 125.2 (arom. Fmoc), 127.1 (arom. 752 
Fmoc), 127.6 (arom. Fmoc), 132.3 (arom. Pbf), 132.7 (arom. Pbf), 138.3 (arom. 753 
Pbf), 141.1 (arom. Fmoc), 143.7 (arom. Fmoc), 144.5 (O-CH2-C=), 156.4 (arom. 754 
Pbf), 158.7 (-O-C arom. Pbf), 172.2 (Arg, Cα-CO-NH-), 173.5 (Arg, Cα-CO-NH) 755 
MALDI-TOF MS (m/z): calcd for C75H108N12O20S2, 1560.72; found, [M+H]+ = 756 
1559.755, [M+Na]+ = 1581.722, [M+K]+ = 1597.671 757 
 758 
1-[2,3,4,6-Tetra-O-methyl-β-D-glucopyranosyl-(1→4)-2,3,6-tri-O-methyl-β-759 
D-glucopyranosyl]-4-(Arg-Arg-NH-CH2)-1H-1,2,3-triazole (2a) 760 
1-[2,3,4,6-Tetra-O-methyl-β-D-glucopyranosyl-(1→4)-2,3,6-tri-O-methyl-β-D-761 
glucopyranosyl]-4-(Nα-Fmoc-Nω-Pbf-L-arginine-Nω-Pbf-L-arginine-N-methyl)-762 
1H-1,2,3-triazole (5a, 61 mg, 0.039 mmol) was dissolved in 763 
piperidine/dichloromethane (1/1, v/v, 1 mL). The reaction mixture was stirred 764 
under nitrogen at room temperature for 1 h and then concentrated to dryness. The 765 
crude product was purified by preparative TLC (eluent: 15:85 (v/v) 766 
methanol/dichloromethane) to give 1-[2,3,4,6-tetra-O-methyl-β-D-767 
glucopyranosyl-(1→4)-2,3,6-tri-O-methyl-β-D-glucopyranosyl]-4-(Nω-Pbf-L-768 
arginine-Nω-Pbf-L-arginine-N-methyl)-1H-1,2,3-triazole (34 mg, 0.025 mmol, 769 
65% yield; MALDI-TOF MS (m/z): calcd for C60H96N12O18S2, 1336.64; found, 770 
[M+Na]+ = 1359.5). 771 
1-[2,3,4,6-Tetra-O-methyl-β-D-glucopyranosyl-(1→4)-2,3,6-tri-O-methyl-β-D-772 
glucopyranosyl]-4-(Nω-Pbf-L-arginine-Nω-Pbf-L-arginine-N-methyl)-1H-1,2,3-773 
triazole (31 mg, 0.023 mmol) was dissolved in TFA/distilled water (8/2, v/v, 1.0 774 
mL) and stirred under nitrogen at 37 °C for 4 h. The reaction mixture was 775 
concentrated to dryness and the crude product was purified by gel-filtration 776 
42 
column chromatography (LH-20, eluent: methanol) to give 1-[2,3,4,6-tetra-O-777 
methyl-β-D-glucopyranosyl-(1→4)-2,3,6-tri-O-methyl-β-D-glucopyranosyl]-4-778 
(Arg-Arg-NH-CH2)-1H-1,2,3-triazole (2a, 10 mg, 0.012 mmol, 52% yield).  779 
1H-NMR (500 MHz, D2O): δ 1.5-1.7 (m, 4H, Hγ and Hγ'), 1.73-1.83 (m, 2H, 780 
Hβ), 1.85-1.95 (m, 2H, Hβ'), 3.09 (s, 3H, OCH3), 3.12 (t, J=9.5 Hz, H2'), 3.12-781 
3.25 (m, 4H, Hδ and Hδ'), 3.29 (t, J=9.0 Hz, H4'), 3.36 (t, J=9.0 Hz, H3'), 1H, 782 
3.36 (s, 3H, OCH3), 3.42 (s, 3H, OCH3), 3.46 (m, 1H, H5'), 3.54 (s, 3H, OCH3), 783 
3.60 (s, 3H, OCH3), 3.63 (s, 3H, OCH3), 3.63 (s, 3H, OCH3), 3.67-3.75 (2H, H6'), 784 
3.70 (t, 1H, J=9.5 Hz, H3), 3.72-3.78 (2H, H6), 3.81 (t, 1H, J=9.0 Hz, H2), 3.89 (t, 785 
1H, J=9.0 Hz, H4), 3.97 (m, 1H, H5), 4.04 (broad s, 1H, Hα'), 4.30 (t, 1H, J=6.5 786 
Hz, Hα (near sugar residue)), 4.44 (d, 1H, J=8.0 Hz, H1'), 4.44 (d, 1H, J=14.5 Hz, 787 
NHCH2-triazole), 4.57 (d, 1H, J=15.5 Hz, OCH2-triazole), 5.75 (d, 1H, J=9.5 Hz, 788 
H1), 8.19 (s, 1H, CH, triazole) 789 
13C-NMR (125 MHz, D2O): δ 26.0 (Cγ'), 26.9 (Cγ), 30.6 (Cβ or Cβ'), 30.8 (Cβ 790 
or Cβ'), 36.8 (NHCH2-triazole), 43.0 (Cδ or Cδ'), 43.1 (Cδ or Cδ'), 51.5 (Cα'), 791 
56.6 (Cα (near sugar residue)), 61.0 (OCH3), 61.1 (OCH3), 62.4 (OCH3), 62.5 792 
(OCH3), 62.6 (OCH3), 62.7 (OCH3), 63.2 (OCH3), 72.5 (C6), 73.1 (C6'), 76.1 793 
(C5'), 78.7 (C4), 79.3 (C5), 81.4 (C4'), 84.0 (C2), 85.4 (C2'), 86.0 (C3), 87.8 (C3'), 794 
88.9 (C1), 105.1 (C1'), 126.2 (CH of triazole), 147.5 (quaternary C of triazole). 795 
159.4 (quaternary C of guanidino group of arginine), 159.4 (quaternary C of 796 
guanidino group of arginine), 175.8 (Cα-CO-NH-), 175.9 (Cα'-CO-NH-) 797 
MALDI-TOF MS (m/z): calcd for C34H64N12O12, 832.48; found, [M+H]+ = 798 





triazole (6a)  803 
To a solution of 2,3,4,6-tetra-O-methyl-β-D-glucopyranosyl-(1→4)-2,3,6-tri-O-804 
methyl-β-D-glucopyranosyl azide (7a, 25 mg, 0.054 mmol) and Fmoc-805 
Glu(OtBu)-Glu(OtBu)-NH-CH2CCH (10, 35 mg, 0.054 mmol) in 3 mL of 806 
methanol/dichloromethane (1/4, v/v) were added CuBr (77 mg, 0.054 mmol, 10 807 
equiv.) and aqueous sodium ascorbate (213 mg/269 µL). The reaction mixture 808 
was stirred under nitrogen at room temperature for 2 h, after which it was purified 809 
by PTLC (eluent: 1:9 (v/v) methanol/dichloromethane) to give 1-(2,3,4,6-tetra-O-810 
methyl-β-D-glucopyranosyl-(1→4)-2,3,6-tri-O-methyl-β-D-glucopyranosyl)-4-811 
[Nα-Fmoc-Glu(Ot-Bu)-Glu(Ot-Bu)-N-methyl]-1H-1,2,3-triazole (52 mg, 0.047 812 
mmol, 87% yield). 813 
1H-NMR (500 MHz, CDCl3): δ: 1.42 (s, 9H, CH3 (tBu)), 1.46 (s, 9H, CH3 (tBu)), 814 
1.90-2.02 (m, 2H, Hβ), 2.02-2.20 (m, 2H, Hβ), 2.26-2.48 (m, 4H, Hγ), 2.96 (t, 1H, 815 
J=8.5 Hz, H2’Me), 3.14 (t, 1H, J=9.0 Hz, H3’Me), 3.15 (s, 3H, OCH3), 3.20 (t, 1H, 816 
J=8.5 Hz, H4’Me), 3.23-3.28 (H5’Me), 3.30 (s, 3H, OCH3), 3.39 (t, 1H, J=8.5 Hz, 817 
H3Me), 3.42 (s, 3H, OCH3), 3.54 (s, 3H, OCH3), 3.56 (s, 3H, OCH3), 3.62 (s, 3H, 818 
OCH3), 3.63 (s, 3H, OCH3), 3.54-3.58 (m, H5Me), 3.58-3.67 (3H, H6Me, H6’Me), 819 
3.64 (t, 1H, J=9.0 Hz, H2Me), 3.6-3.75 (dd, 1H, J=4.5 Hz, J=11.0 Hz, H6Me), 3.79 820 
(t, 1H, J=9.5 Hz, H4Me), 4.12 (m, 1H, Hα), 4.20 (t, 1H, J=4.5 Hz, CH (Fmoc)), 821 
4.32 (d, 1H, J=8.0 Hz, H1Me), 4.35 (broad d, 2H, J=7.0 Hz, CH2 (Fmoc)), 4.43 (m, 822 
1H, Hα), 4.54 (broad d, J=5.5 Hz, NH-CH2-triazole), 5.39 (d, 1H, J=9.0 Hz, H1Me), 823 
6.07 (d, J=6.0 Hz, NH-Cα), 7.28-7.78 (8H, arom. Fmoc), 7.74 (broad s, triazole 824 
H) 825 
44 
13C-NMR (125 MHz, CDCl3): δ 27.0 (triazole-CH2-NH-Cα-Cβ-), 27.3 (Cβ-Cα-826 
NH-Fmoc), 28.0 (CH3 (tBu)), 28.0 (CH3 (tBu)), 31.8 (triazole-CH2-NH-Cα-Cβ-827 
Cγ), 31.8 (Cγ-Cβ-Cα-NH-Fmoc), 35.1 (triazole-CH2-NH-), 47.1 (CH, Fmoc), 828 
53.0 (triazole-CH2-NH-CO-Cα-NH-), 55.3 (-CO-Cα-NH-Fmoc), 59.0 (OCH3), 829 
59.3 (OCH3), 60.3 (OCH3), 60.3 (OCH3), 60.6 (OCH3), 60.7 (OCH3), 60.8 (OCH3), 830 
67.1 (CH2, Fmoc), 70.0 (C6), 71.1 (C6'), 74.7 (C5'), 77.1 (C4), 77.8 (C5), 79.3 831 
(C4'), 81.1 (C(CH3)3), 81.3 (C(CH3)3), 81.9 (C2), 84.0 (C2'), 85.3 (C3), 86.9 (C3'), 832 
87.2 (C1), 103.2 (C1'), 119.9 (arom. Fmoc), 121.6 (triazole CH), 125.2 (arom. 833 
Fmoc), 127.1 (arom. Fmoc), 127.1 (arom. Fmoc), 127.7 (arom. Fmoc), 141.2 834 
(arom. Fmoc), 141.3 (arom. Fmoc), 143.7 (arom. Fmoc), 143.9 (arom. Fmoc), 835 
144.8 (O-CH2-C=), 156.6 (CO Fmoc), 171.0 (Glu, triazole-CH2-NH-CO-Cα-NH-), 836 
171.6 (Glu, -CO-Cα-NH-Fmoc), 173.1 (Glu, Cδ), 173.1 (Glu, Cδ) 837 
MALDI-TOF MS (m/z): calcd for C55H80N6O18, 1112.55; found, [M+Na]+ = 838 
1135.615, [M+K]+ = 1151.583 839 
 840 
1-[2,3,4,6-Tetra-O-methyl-β-D-glucopyranosyl-(1→4)-2,3,6-tri-O-methyl-β-841 
D-glucopyranosyl]-4-(Glu-Glu-NH-CH2)-1H-1,2,3-triazole (3a) 842 
1-[2,3,4,6-Tetra-O-methyl-β-D-glucopyranosyl-(1→4)-2,3,6-tri-O-methyl-β-D-843 
glucopyranosyl]-4-[Nα-Fmoc-Glu(Ot-Bu)-Glu(Ot-Bu)-N-methyl]-1H-1,2,3-844 
triazole (6a, 46 mg, 0.034 mmol) was dissolved in piperidine/dichloromethane 845 
(1/1, v/v, 1 mL). The reaction mixture was stirred under nitrogen at room 846 
temperature for 1 h, and then concentrated to dryness. The crude product was 847 
purified by PTLC (eluent: methanol/dichloromethane (15/85, v/v)) to give 1-848 
[2,3,4,6-tetra-O-methyl-β-D-glucopyranosyl-(1→4)-2,3,6-tri-O-methyl-β-D-849 
45 
glucopyranosyl]-4-[Glu(Ot-Bu)-Glu(Ot-Bu)-N-methyl]-1H-1,2,3-triazole (24 mg, 850 
0.016 mmol, 47% yield). 851 
1-[2,3,4,6-Tetra-O-methyl-β-D-glucopyranosyl-(1→4)-2,3,6-tri-O-methyl-β-D-852 
glucopyranosyl]-4-(Glu(Ot-Bu)-Glu(Ot-Bu)-N-methyl)-1H-1,2,3-triazole (66 mg, 853 
0.079 mmol) was dissolved in TFA/dichloromethane (9/1, v/v, 1 mL) and stirred 854 
under nitrogen at room temperature for 4 h. The crude product was purified by 855 
gel-filtration chromatography (LH-20, eluent: methanol) to give 1-[2,3,4,6-tetra-856 
O-methyl-β-D-glucopyranosyl-(1→4)-2,3,6-tri-O-methyl-β-D-glucopyranosyl]-4-857 
(Glu-Glu-N-methyl)-1H-1,2,3-triazole (3a, 36 mg, 0.046 mmol, 58% yield). 858 
1H-NMR (500 MHz, D2O): δ 1.9-2.1 (m, 2H, Hβ), 2.2-2.3 (m, 2H, Hβ), 2.3-2.6 859 
(m, 4H, Hγ), 3.12 (t, 1H, J=8.5 Hz, H2’Me), 3.29 (t, 1H, J=9.5 Hz, H4’Me), 3.36 (t, 860 
1H, J=8.5 Hz, H3’Me), 3.36 (s, 3H, OCH3), 3.42 (s, 3H, OCH3), 3.43-3.48 (H5’Me), 861 
3.54 (s, 3H, OCH3), 3.60 (s, 3H, OCH3), 3.62 (s, 3H, OCH3), 3.63 (s, 6H, OCH3), 862 
3.7 (H3Me), 3.80 (t, 1H, J=9.5 Hz, H2Me), 3.89 (t, 1H, J=9.5 Hz, H4Me), 3.93-3.98 863 
(m, 1H, H5Me), 3.65-3.83 (H6’Me, H6Me), 3.79 (t, 1H, J=9.5 Hz, H4Me), 3.86 (m, 1H, 864 
H5Me), 4.2-4.5 (broad s, 1H, Hα), 4.34 (d, 1H, J=8.0 Hz, H1’Me), 4.4-4.61 (NH-865 
CH2-triazole), 5.75 (broad d, 1H, J=7.0 Hz, H1Me), 8.24 (broad s, triazole CH) 866 
13C-NMR (125 MHz, D2O): δ 27.9 (Cβ'), 29.0 (Cβ), 31.9 (Cγ and Cγ'), 37.1 867 
(NHCH2-triazole), 56.1 (Cα (near sugar residue)), 59.4 (Cα'), 61.1 (OCH3), 61.2 868 
(OCH3), 62.2 (OCH3), 62.5 (OCH3), 62.6 (OCH3), 62.7 (OCH3), 63.2 (OCH3), 869 
72.5 (C6 or C6'), 73.1 (C6 or C6'), 76.1 (C5'), 78.7 (C4), 79.4 (C5), 81.5 (C4'), 870 
84.0 (C2), 85.5 (C2'), 86.0 (C3), 87.8 (C3'), 89.1 (C1), 105.2 (C1'), 126.6 (CH of 871 
triazole), 177.6 (Cα-CO-NH-, and Cα'-CO-NH-), 184.9 (Cγ-(CO)OH, Cγ'-872 
(CO)OH)  873 
46 
MALDI-TOF MS (m/z): calcd for C32H54N6O16, 778.36; found, [M+H]+ = 874 
779.518, [M+Na]+ = 801.530, [M+K]+ = 817.504 875 
 876 
1-(Tri-O-methylcellulosyl)-4-(Nα-Fmoc-Nω-Pbf-L-arginine-Nω-Pbf-L-877 
arginine-N-methyl)-1H-1,2,3-triazole (5b)  878 
Sodium ascorbate (227 mg/287 μL, 1.15 mmol, 20 equiv., 4 M in H2O) and 879 
CuSO4⋅5H2O (143 mg, MW = 249.69, 0.573 mmol, 10 equiv.) were added to a 880 
solution of 2-propynyl Nα-Fmoc-Nω-Pbf-L-arginine-Nω-Pbf-L-arginine-N-881 
propargylamide (9, 100 mg, MW = 788.8, 0.127 mmol, 2.2 equiv.) and tri-O-882 
methylcellulosyl azide (7b, 419 mg, Mn = 7.34 × 103, DPn = 35.8, 0.0571 mmol, 883 
1.0 equiv.) in methanol/dichloromethane (1/4, v/v, 10 mL). The reaction mixture 884 
was stirred at room temperature for 14 h under nitrogen, after which it was 885 
concentrated and passed through a silica-gel chromatography column (eluent: 886 
20% MeOH/CH2Cl2) to give the crude product. The crude product was purified by 887 
gel-filtration column chromatography (LH-60, eluent: 20% MeOH/CH2Cl2) to 888 
give 1-(tri-O-methylcellulosyl)-4-(Nα-Fmoc-Nω-Pbf-L-arginine-Nω-Pbf-L-889 
arginine-N-methyl)-1H-1,2,3-triazole (5b, 420 mg, quantitative yield; GPC 890 
analysis: Mn = 5.6 × 103, Mw / Mn = 1.8). 891 
1H-NMR (500 MHz, CDCl3): δ: 1.44 (CH3, Pbf), 2.07 (CH3, Pbf), 2.47-2.56 892 
(CH3, Pbf), 2.92 (CH2, Pbf), 2.96 (t, J=8.5 Hz, H2Me (internal)), 3.21 (t, 1H, J=9.0 893 
Hz, H3Me (internal)), 3.29 (m, J=9.0 Hz, H5Me (internal)), 3.39 (s, OCH3), 3.54 (s, 894 
OCH3), 3.58 (s, OCH3), 3.69 (t, J=9.0, H4Me (internal)), 3.6-3.73 (m, H6Me 895 
(internal)), 3.77 (m, H6Me (internal)), 4.34 (d, J=8.0 Hz, H1 Me (internal)), 6.12 896 
(H1αMe), 6.1-6.7, 7.24 (Fmoc), 7.35 (Fmoc), 7.57 (Fmoc), 7.62 (d, J = 7.0 Hz, 897 
Fmoc), 7.82. 898 
47 
13C-NMR (125 MHz, CDCl3): δ 12.5 (CH3, Pbf), 17.9 (CH3, Pbf), 19.3 (CH3, 899 
Pbf), 25.5 (Cγ), 28.6 (CH3, Pbf), 40.9 (Cδ), 43.2 (CH2, Pbf), 47.0 (CH, Fmoc), 900 
59.1 (OCH3), 60.3 (OCH3), 60.5 (OCH3), 67.3 (CH2, Fmoc), 70.3 (C6), 74.8 (C5), 901 
77.4 (C4), 83.5 (C2), 85.0 (C3), 86.4 (CH, Fmoc), 103.1 (C1), 117.6 (arom. Pbf), 902 
119.9 (arom. Fmoc), 124.7 (arom. Pbf), 125.2 (arom. Fmoc), 127.1 (arom. Fmoc), 903 
127.7 (arom. Fmoc), 132.3 (arom. Pbf), 132.7 (arom. Pbf), 138.3 (arom. Pbf), 904 
141.1 (arom. Fmoc), 143.7 (arom. Fmoc), 156.4 (arom. Pbf), 158.8 (-O-C arom. 905 
Pbf) 906 
FT-IR (KBr): 3442, 2930, 2836, 1722, 1663, 1622, 1551, 1454, 1375, 1310, 907 




triazole (2b)  912 
1-(Tri-O-methylcellulosyl)-4-(Nα-Fmoc-Nω-Pbf-L-arginine-Nω-Pbf-L-913 
arginine-N-methyl)-1H-1,2,3-triazole (5b, 293 mg) was dissolved in 914 
piperidine/dichloromethane (1/1, v/v, 4 mL). The reaction mixture was stirred at 915 
room temperature for 4 h under nitrogen, after which it was concentrated and 916 
purified by gel-filtration column chromatography (LH-60, eluent: 20% 917 
MeOH/CH2Cl2) to give 1-(tri-O-methylcellulosyl)-4-(Nω-Pbf-L-arginine-Nω-Pbf-918 
L-arginine-N-methyl)-1H-1,2,3-triazole (260 mg, 89% yield; GPC analysis: Mn = 919 
6.7 × 103, Mw / Mn = 1.7). 920 
1-(Tri-O-methylcellulosyl)-4-(Nω-Pbf-L-arginine-Nω-Pbf-L-arginine-N-921 
methyl)-1H-1,2,3-triazole (244 mg) was dissolved in trifluoroacetic acid/distilled 922 
water (1/4, v/v, 2 mL) and stirred at 37 °C for 4 h under nitrogen. The mixture 923 
48 
was concentrated, purified by gel-filtration column chromatography (LH-60, 924 
eluent: 20% MeOH/CH2Cl2), and further purified by PTLC (eluent: 10% 925 
MeOH/CH2Cl2). The purified 1-(tri-O-methyl-cellulosyl)-4-(L-arginine-L-926 
arginine-N-methyl)-1H-1,2,3-triazole was dispersed in water. Water-soluble 927 
component was collected by removal of the water-insoluble component by 928 
filtration through cotton wool, which was then concentrated to give 1-(tri-O-929 
methylcellulosyl)-4-(L-arginine-L-arginine-N-methyl)-1H-1,2,3-triazole (2b, 186 930 
mg, 76% yield, GPC analysis: Mn = 6.0 × 103, Mw / Mn = 1.6). 931 
1H-NMR (500 MHz, D2O): δ 1.5-2.0 (m, Hγ and Hγ', Hβ, Hβ'), 3.13 (t, J= 8.5 932 
Hz, H2Me), 3.40 (s, OMe), 3.45 (t, J = 9.5 Hz, H3Me), 3.56 (s, OMe), 3.58 (s, OMe), 933 
3.55-3.60 (H5Me), 3.68-3.80 (H4Me, H6Me), 4.42 (d, J = 7.5 Hz, H1Me), 4.65 (d, J = 934 
8.0 Hz), 4.99 (d, J = 3.5 Hz), 5.40 (d, J = 3.5 Hz), 5.62 (broad s), 8.42 (s, CH, 935 
triazole) 936 
FT-IR (KBr): 3446, 2922, 2836, 1624, 1456, 1375, 1314, 1125, 1078, 947, 768, 937 
702, 662, 606, 581, 538, 488 cm-1 938 
 939 
1-(Tri-O-methyl-cellulosyl)-4-[Fmoc-Glu(Ot-Bu)-Glu(Ot-Bu)-N-methyl]-940 
1H-1,2,3-triazole (6b) 941 
Sodium ascorbate (109 mg/137 μL, 0.55 mmol, 20 equiv., 4 M in H2O) and 942 
CuSO4⋅5H2O (68 mg, MW = 249.69, 0.27 mmol, 10 equiv.) were added to a 943 
solution of Nα-Fmoc-Glu(Ot-Bu)-Glu(Ot-Bu)-N-propargylamide (10, 53 mg, 944 
MW = 647.77, 0.082 mmol, 3.0 equiv.) and tri-O-methylcellulosyl azide (7b, 200 945 
mg, Mn = 7.34 × 103, DPn = 35.8, 0.027 mmol, 1.0 equiv.) in 946 
methanol/dichloromethane (1/4, v/v, 5 mL). The reaction mixture was stirred at 947 
room temperature for 14 h under nitrogen, after which it was concentrated and 948 
49 
passed through a silica-gel chromatography column (eluent: 20% MeOH/CH2Cl2). 949 
The crude product was purified by gel-filtration column chromatography (LH-60, 950 
eluent: 20% MeOH/CH2Cl2), and then by PTLC (eluent: 10% MeOH/CH2Cl2) to 951 
give 1-(tri-O-methylcellulosyl)-4-[Fmoc-Glu(Ot-Bu)-Glu(Ot-Bu)-N-methyl]-1H-952 
1,2,3-triazole (186 mg, 93% yield, GPC analysis: Mn = 7.4 × 103, Mw / Mn = 1.6). 953 
1H-NMR (500 MHz, CDCl3): δ 1.43 (s, CH3 (tBu)), 1.47 (s, CH3 (tBu)), 2.0-2.2 954 
(m, 4H, Hβ), 2.25-2.450 (m, 4H, Hγ), 2.96 (t, J= 8.5 Hz, H2Me), 3.22 (t, J= 9.0 Hz, 955 
H3Me), 3.29 (m, H5Me), 3.39 (s, OMe), 3.54 (s, OMe), 3.59 (s, OMe), 3.64-3.74 956 
(H4Me), 3.64-3.82 (H6Me), 4.1-4.2 (1H, Hα), 4.25-4.35 (2H, CH2 (Fmoc)), 4.35 (d, 957 
J= 7.5 Hz, H1Me), 7.32 (t, J= 7.5 Hz, arom., Fmoc), 7.40 (t, J= 7.5 Hz, arom., 958 
Fmoc), 7.62 (broad d, J= 7.0 Hz, arom., Fmoc), 7.76 (d, J= 7.5 Hz, arom., Fmoc) 959 
13C-NMR (125 MHz, CDCl3): δ 28.0 (CH3 (tBu)), 28.0 (CH3 (tBu)), 31.9 960 
(triazole-CH2-NH-Cα-Cβ-Cγ), 35.2 (triazole-CH2-NH-), 47.1 (CH, Fmoc), 59.1 961 
(OCH3), 59.6, 60.1, 60.3 (OCH3), 60.4, 60.5 (OCH3), 60.8, 67.2 (CH2, Fmoc), 962 
70.3 (C6), 72.2, 73.2, 73.2, 74.9 (C5), 77.4 (C4), 81.2 (C(CH3)3), 83.5 (C2), 85.0 963 
(C3), 86.1, 103.1 (C1), 120.0 (arom. Fmoc), 125.1 (arom. Fmoc), 127.1 (arom. 964 
Fmoc), 127.7 (arom. Fmoc), 141.3 (arom. Fmoc), 143.8 (arom. Fmoc), 144.4 965 
(arom. Fmoc) 966 
FT-IR (KBr): 3430, 2932, 2904, 2836, 1728, 1672, 1514 (tBu), 1454, 1373, 967 
1312, 1125, 1084, 1059, 951, 889, 851, 762, 743 (Fmoc), 704, 656, 615, 577 cm-1 968 
 969 
1-(Tri-O-methyl-cellulosyl)-4-(Glu-Glu-N-methyl)-1H-1,2,3-triazole (3b) 970 
1-(Tri-O-methyl-cellulosyl)-4-[Fmoc-Glu(Ot-Bu)-Glu(Ot-Bu)-N-methyl]-1H-971 
1,2,3-triazole (161 mg) was dissolved in piperidine/dichloromethane (1/1, v/v, 2 972 
mL). The reaction mixture was stirred at room temperature for 4 h under nitrogen, 973 
50 
after which it was concentrated and purified by gel-filtration column 974 
chromatography (LH-60, eluent: 20% MeOH/CH2Cl2), and then by PTLC (eluent: 975 
10% MeOH/CH2Cl2) to give 1-(tri-O-methylcellulosyl)-4-[Glu(Ot-Bu)-Glu(Ot-976 
Bu)-N-methyl]-1H-1,2,3-triazole (136 mg, 84% yield; GPC analysis: Mn = 977 
8.0 × 103, Mw / Mn = 1.6).  978 
1-(Tri-O-methylcellulosyl)-4-[Glu(Ot-Bu)-Glu(Ot-Bu)-N-methyl]-1H-1,2,3-979 
triazole (124 mg) was dissolved in trifluoroacetic acid/distilled water (9/1, v/v, 1 980 
mL). The reaction mixture was stirred at room temperature for 4 h under nitrogen 981 
atmosphere, concentrated, and then purified by gel-filtration column 982 
chromatography (LH-60, eluent: 20% MeOH/CH2Cl2), and further purified by 983 
PTLC) eluent: 10% MeOH/CH2Cl2). The water-soluble component was collected 984 
by removal of the water-insoluble component by filtration, and concentrated to 985 
give 1-(tri-O-methylcellulosyl)-4-(Glu-Glu-N-methyl)-1H-1,2,3-triazole (3b, 64 986 
mg, 52% yield; GPC analysis: Mn = 7.0 × 103, Mw / Mn =1.6). 987 
1H-NMR (500 MHz, D2O): δ 3.14 (t, J = 9.0 Hz, H2Me), 3.40 (s, OMe), 3.45 (t, J 988 
= 9.0 Hz, H3Me), 3.57 (s, OMe), 3.58 (s, OMe), 3.57-3.62 (H5Me), 3.60-3.82 (H4Me, 989 
H6Me), 4.43 (d, J = 8.0 Hz, H1Me), 4.48 (d, 5.40 (d, J = 3.0  Hz), J = 3.5 Hz), 5.43 990 
(broad s), 8.43 (s, triazole CH) 991 
FT-IR (KBr): 3460, 2928, 2836, 1732, 1626, 1458, 1377, 1310, 1126, 1084, 992 
1061, 945, 800, 704, 664, 571, 486 cm-1 993 
Characterization 994 
General 995 
1H- and 13C-NMR spectra were recorded on a Varian 500 NMR (500 MHz) or 996 
Varian INOVA300 (300 MHz) spectrometer in chloroform-d with 997 
tetramethylsilane as the internal standard, or in deuterium oxide with 3-998 
51 
(trimethylsilyl)-1-propanesulfonic acid sodium salt as the external standard. 999 
Chemical shifts (δ) and coupling constants (J) are given in ppm and Hz, 1000 
respectively. Matrix-assisted laser-desorption/ionization time-of-flight mass 1001 
spectrometry (MALDI-TOF MS) was performed on a Bruker MALDI-TOF 1002 
Autoflex III mass spectrometer in positive ion and reflector or linear modes. A 1003 
smartbeam laser was used for ionization. All spectra were acquired in linear mode 1004 
and calibrated externally. 2,5-Dihydroxybenzoic acid was used as the matrix in 1005 
MALDI-TOF MS experiments. Shimadzu components, namely the liquid 1006 
chromatography injector (LC-10ATvp), column oven (CTO-10Avp), ultraviolet-1007 
visible detector (SPD-10Avp), refractive index detector (RID-10A), 1008 
communication bus module (CBM-10A), and LC workstation (CLASS-LC10), 1009 
were used for HPLC separations, with Shodex columns (KF802, KF802.5, and 1010 
KF805). Number- and weight-averaged molecular weights (Mn, Mw) and 1011 
polydispersity indices (Mw/Mn) were determined using polystyrene standards 1012 
(Shodex). A flow rate of 1 mL/min at 40 °C was chosen, and chloroform was used 1013 
as the eluent. 1014 
Differential scanning calorimetry (DSC) 1015 
DSC thermograms were recorded on a DSC823e instrument (Mettler Toledo, 1016 
Zurich, Switzerland) with an HSS7 sensor under nitrogen during (0 → 90 → 0 °C) 1017 
heating/cooling cycles, with heating and cooling rates of 3.5 °C/min. Each 1018 
temperature cycle was repeated three times in order to ensure reproducibility. 1019 
Sample concentrations of 2.0 wt% were used in DSC experiments. 1020 
Dynamic light scattering (DLS) experiments 1021 
DLS experiments were performed with an ELS-Z zeta-potential and particle-1022 
size analyzer (Otsuka Electronics Co., Ltd, Osaka, Japan) and conducted in the 1023 
52 
10–90 °C temperature range. Sample solutions were maintained at the required 1024 
temperature for 5 min prior to each experiment. Sample concentrations of 0.2 wt% 1025 
were used in these experiments.  1026 
Surface-tension measurements 1027 
Surface tensions were measured with a CBVP-A3 surface tensiometer (Kyowa 1028 
Interface Science, Co. Ltd., Tokyo, Japan) at 23 °C using the Wilhelmy method. 1029 
A Teflon cell containing 700 μL of the required solution was used in these 1030 
experiments. Surface tensions gradually decreased with time, and stable values 1031 
were recorded after 30 min. 1032 
Scanning electron microscopy (SEM) and transmission electron 1033 
microscopy (TEM) 1034 
The three hydrogels from aqueous solutions containing compounds 1b, 2b, and 1035 
3b were frozen in liquid nitrogen, lyophilized, and cut with a razor blade. The cut 1036 
surfaces of the hydrogels were sputter-coated with gold with an ion-coater (JFC-1037 
1100E, JEOL, Tokyo, Japan) and examined by scanning electron microscopy 1038 
(SEM, JSM-6060, JEOL) at an accelerator voltage of 5 kV. 1039 
A drop of an aqueous dispersion of compound 2b was mounted on a copper grid 1040 
with an elastic carbon-support film (Oken Shoji, Tokyo, Japan) and examined by 1041 
transmission electron microscopy (TEM, JEM1400, JEOL) at an accelerator 1042 
voltage of 100 kV after negative staining with uranyl acetate. 1043 
Release of model drugs from the thermoresponsive hydrogels  1044 
Compounds 2b and 3b (2 or 4 mg) were respectively added to glass vials 1045 
containing solutions of diclofenac sodium (DFNa) or imipramine hydrochloride 1046 
(IMC) (0.025 wt%) in PBS (100 µL), and the compounds were dissolved at about 1047 
0 °C. The glass vial was then heated at 37 °C for 10 min while left to stand. After 1048 
53 
a hydrogel had formed, a fresh PBS solution (500 µL), which had been pre-heated 1049 
to 37 °C, was carefully poured onto the hydrogel surface. The glass vial was 1050 
shaken at 60 rpm in a water-bath shaker (Eyela NTS-4000, Tokyo Rikakikai Co., 1051 
Ltd.). The aqueous layer (500 µL) was then collected and filtered through a 1052 
membrane filter (pore size: 0.45 µm). The UV absorbance of the aqueous solution 1053 
was recorded at 260 nm in a 96-well microplate using a SpectraMax Plus 384 1054 
Microplate Reader (Molecular Devices). The amount of released drug was 1055 
evaluated from the UV absorbance. 1056 
Cytotoxicity assays 1057 
Compounds 1b, 2b, and 3b were dispersed in PBS at a concentration of 20 1058 
mg/mL and serially diluted by factors of two in a 96-well flat-bottomed plate (50 1059 
µL/well (Corning Inc., Corning, NY). The human histocytoma U937 cell line was 1060 
suspended in complete RPMI1640 medium at 1 × 104 cells/mL and the cell 1061 
suspension was added to the 96-well flat bottom plate (5 × 102 cells/50 µl/well). 1062 
The plate was incubated at 37 °C in a 5%-CO2 atmosphere for 4 d. The plate was 1063 
allowed to stand at room temperature for 30 min, after which 100 µL of CellTiter-1064 
Glo Luminescent Cell Viability Assay reagent (Promega Corp., Madison, WI) 1065 
was added to each well. After thorough mixing, the contents of each well were 1066 
transferred into an OptiplateTM-96 multi-well plate (Perkin Elmer, Waltham, MA). 1067 
Cell viability was determined by measuring luminescence with an ARVOTM SX 1068 
Delfia 1420 Multilabel Counter (Perkin Elmer Life and Analytical Sciences, 1069 
Shelton, CT). 1070 
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